Records containing: Ovarian Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-12-10Outcomes of First-line Olaparib Mono-maintenance Therapy in Newly Diagnosed Ovarian Cancer Patients With tBRCA Wild-type Tumors: a Realworld Study
-
CLINICAL_TRIALS study record update · 2021-10-26Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2021-09-27A Multicountry, Multicenter, Retrospective Study Evaluating the Patient Characteristics, Disease Burden, Treatment Patterns, and Patient Journey of Advanced Epithelial Ovarian Cancer Patients: A Korean, Taiwanese, and Australian Secondary Database Study
-
CLINICAL_TRIALS study record update · 2021-09-08Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.
-
CLINICAL_TRIALS study record update · 2021-08-25Randomized Phase III Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-08-10Atezolizumab in Combination With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients With Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-07-21OVI-DETECT Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-05-17A Phase Ib and Randomised Phase II Trial of Pazopanib With or Without Fosbretabulin in Advanced Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-04-08Phase 1/2 Study of ZK-Epothilone (ZK-Epo; ZK-219477) in Combination With Carboplatin in Patients With Platinum-sensitive Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2021-03-18A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
-
CLINICAL_TRIALS study record update · 2021-01-20The nCYT Study: A Powered Study to Evaluate the Sensitivity and Specificity of Cytological Evaluation of Fallopian Tube Samples Collected by the Cytuity in Determining the Presence of Malignancy
-
CLINICAL_TRIALS study record update · 2021-01-19Impact of the COVID-19 Pandemic on Changes in Therapeutic Strategies in Gynecological Oncology
-
CLINICAL_TRIALS study record update · 2020-11-16An Open-Label, Non-Randomized, Multicenter Study to Determine the Pharmacokinetics and Safety of Niraparib Following a Single Oral Dose in Patients With Advanced Solid Tumors and Either Normal Hepatic Function or Moderate Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2020-11-10A Single-arm, Prospective, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-10-06An Open Label Phase II Study to Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-09-22A Phase II, Open-label, Single-arm, Multicenter Study to Evaluate Efficacy and Safety of Pembrolizumab Monotherapy in Subjects With Advanced Recurrent Ovarian Cancer (KEYNOTE-100)
-
CLINICAL_TRIALS study record update · 2020-09-14Phase 2: A Randomized Controlled Study on Effectiveness of Chemotherapy (Carboplatin-Paclitaxel) Versus Chemo-immunotherapy (Carboplatin-Paclitaxel-Oregovomab) in Patients With Advanced Epithelial Ovarian, Adnexal or Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2020-08-27A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-08-20A Phase Ib Study to Evaluate the Safety and Tolerability of Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2020-06-11A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2020-05-29A Phase III Clinical Trail of Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-05-12Gynacological Imaging Reporting and Data System in Classifying Ovarian Masses on the Basis of Ultrasonography
-
CLINICAL_TRIALS study record update · 2020-04-20Breast, Ovarian and Endometrial Cancer Case-Control Study in Poland
-
CLINICAL_TRIALS study record update · 2020-04-09A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
-
CLINICAL_TRIALS study record update · 2020-03-24Sentinel Node in Ovarian Cancer: SONAR-2